FIELD: medicine.
SUBSTANCE: invention relates to cellular biology and biotechnology, in particular to the use of hUTC cells, a method of reducing and a kit for reducing the production of one or more pro-inflammatory mediators TNF-α, RANTES, IL-1β and combinations thereof in a patient with chronic obstructive pulmonary disease (COPD). Method comprises administering an effective amount of isolated cells derived from human post-natal umbilical cord tissue, essentially free of blood, capable of self-renewal and propagation in culture, not producing CD117 and CD45 and not expressing hTERT or telomerase.
EFFECT: invention enables to reduce production TNF-α, RANTES, IL-1β and combinations thereof in a patient with COPD.
20 cl, 13 dwg, 13 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DETECTION OF CELLS OBTAINED FROM UMBILICAL CORD TISSUE | 2012 |
|
RU2636220C2 |
| COMPOSITION AND METHODS OF CRYOPRESERVATION OF HUTC CELLS | 2017 |
|
RU2748057C2 |
| AMYOTROPHIC LATERAL SCLEROSIS TREATMENT USING CELLS OBTAINED FROM UMBILICAL CORD | 2012 |
|
RU2612391C2 |
| TREATMENT OF DEGENERATIVE CHANGES IN INTERVERTEBRAL DISCS USING CELLS OBTAINED FROM HUMAN UMBILICAL TISSUE | 2012 |
|
RU2645079C2 |
| TREATING PERIPHERAL VASCULAR DISEASES BY MEANS OF UMBILICAL CORD TISSUE CELLS | 2011 |
|
RU2576836C2 |
| ENRICHED NUTRIENT MEDIUM FOR GROWING CELLS DERIVED FROM HUMAN UMBILICAL CORD TISSUE | 2013 |
|
RU2653449C2 |
| ENRICHED NUTRIENT MEDIUM FOR GROWING CELLS DERIVED FROM HUMAN UMBILICAL CORD TISSUE | 2013 |
|
RU2684306C2 |
| TREATMENT OF DISEASE, DISORDERS OR PATHOLOGICAL CONDITIONS OF LUNGS WITH APPLICATION OF PLACENTAL CELLS | 2009 |
|
RU2570550C2 |
| TREATING DISEASES, DISORDERS OR PATHOLOGICAL CONDITIONS OF THE LUNGS USING PLACENTAL CELLS | 2009 |
|
RU2732240C2 |
| AMNIOTIC ADHESIVE CELLS | 2009 |
|
RU2562154C2 |
